ESBER HENRY JEMIL

USNatural personDirector

Insider

ESBER HENRY JEMIL

USNatural personDirector

Transactions

Issuers

Buys / Sells

4/0

Last tx

01 Jul 2019

Behaviour

1 purchase reported after at least 12 months of silence — most recent on 23 Nov 2017.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
NEXMED INC	609,217	reported	03 Jan 2012	tx 15+3,232,768
North Horizon, Inc.	34,656	reported	01 Jul 2019	tx 34+3,179,868−2,949,145
Boston Therapeutics, Inc.	13,000	reported	18 Mar 2015	tx 6+237,000
GALECTIN THERAPEUTICS INC	6,000	reported	08 Feb 2009	tx 3+31,500

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
01 Jul 2019	GRANT_AWARD	North Horizon, Inc.	5,922	1.52 USD	deriv
01 Apr 2019	GRANT_AWARD	North Horizon, Inc.	1,643	5.48 USD	deriv
02 Jan 2019	GRANT_AWARD	North Horizon, Inc.	89,552	0.07 USD	deriv
01 Oct 2018	GRANT_AWARD

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
NEXMED INC	609,217	reported	03 Jan 2012	tx 15+3,232,768
North Horizon, Inc.	34,656	reported	01 Jul 2019	tx 34+3,179,868−2,949,145
Boston Therapeutics, Inc.	13,000	reported	18 Mar 2015	tx 6+237,000
GALECTIN THERAPEUTICS INC	6,000	reported	08 Feb 2009	tx 3+31,500

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
01 Jul 2019	GRANT_AWARD	North Horizon, Inc.	5,922	1.52 USD	deriv
01 Apr 2019	GRANT_AWARD	North Horizon, Inc.	1,643	5.48 USD	deriv
02 Jan 2019	GRANT_AWARD	North Horizon, Inc.	89,552	0.07 USD	deriv
01 Oct 2018	GRANT_AWARD